Zimmer Biomet reports Q3 2025 results; press release attached but not provided in filing text

ZIMMER BIOMET HOLDINGS, INC.

2025-Q3 EPS reported $2.84 vs consensus $1.89 ▲ beat (+50.6%)

Filing furnishes press release under Item 2.02 for quarter ended September 30, 2025.
Exhibit 99.1 (press release) is referenced but its content is not included in the input text.
No specific financial figures or guidance changes can be extracted from the available filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.